Hallucinations in LLMs refer to instances where models generate plausible yet incorrect or unrelated information.

This technology is aimed at enhancing intranasal drug delivery by improving drug ... intended to identify forward-looking statements. For example, the Company is using forward-looking statements ...

In online groups and gyms, users self-experiment and swap information about performance and image-enhancing drugs. While this "broscience" can be dangerous, it can also be used for good, say ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...

Tom Lubnau writes, "The consequences of House Bill 164 are stunning. If a doctor injects a dementia patient with a muscle paralyzer with the intent ...

The Global Oncology Drug market was estimated at $227.2 billion in 2024 and is projected to reach $582.21 billion by 2034 , reflecting a robust CAGR of 11.67% over the forecast period from 2024 to ...

Sosa has faced questions about using performance-enhancing drugs, but he said that wasn’t the reason for his statement. “No. I’m referring, for example, look, 21 years out,” said Sosa, who played his ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

In the corners of the internet where bodybuilders and fitness enthusiasts gather to swap tips on steroids and performance-enhancing drugs, Mair Underwood found herself an unlikely participant. As a ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

On January 7, 2025, the FDA issued a draft guidance called Considerations for the Use of Artificial Intelligence to Support Regulatory ...